406 E2: multiple sclerosis Flashcards

1
Q

MS definition

A

chronic, inflammatory autoimmune disorder that targets both the white and gray matter of the spinal cord and involves the degeneration of CNS myeline or loss of myelin sheath w/ scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MS characteristics

A

-inflammation of the white matter of brain and spinal cord
-demyelination of the nerve fibers
-development of scar tissue (gliosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MS etiology

A

unknown but autoimmune so likely a genetic predisposition that was triggered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MS risk factors

A

age: 20-40
gender: women
location: moderately cool climate
race: caucasian
genetics: fam hx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

possible risk factors for MS

A

smoking
vit D deficiency
obesity
infection (including epstein-barr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MS pathogenesis

A

T lymphocytes migrate to the CNS and cross the blood brain barrier -> antigen antibody reaction in CNS initiates an inflammatory response -> axons are de myelinated & plaques / sclerosis forms -> axons are destroyed
axon is the nerve itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

loss of myelin…

A

disrupts nerve conduction & w/ subsequent death of neurons and brain atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

neurons in early disease

A

-nerve fiber not affected
-impulses still transmitted
-may notice weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

neurons in a more progressed disease

A

-axons are destroyed
-impulses are totally blocked
-permanent loss of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MS subtypes: benign

A

there is an exacerbation of symptoms but after the flare subsides, there is a return to baseline
they recover and there is no loss of function once they are back at baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MS subtypes: relapsing - remitting

A

most common form
long periods of remission w/ few exacerbations, the pt is stable between exacerbations and there is minimal disability or progression of the disease
won’t necessarily return to their baseline & may have some permanent deficits, will be weaker than baseline and each time there is a flare they do not recover all the way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MS subtypes: primary - progressive

A

a gradual progression of symptoms without periods of remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MS subtypes: secondary - progressive

A

there is an initial relapsing or exacerbation followed by remission w/ some loss of function with each exacerbation but changes course and loses the periods of remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS subtypes: progressive - relapsing

A

there is a gradual progression of symptoms and also exacerbations and they have fewer remissions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the most common initial symptoms of MS

A

-paresthesia of the face, trunk or limbs d/t nerves no longer innervating the muscles
-loss of muscle function
-numbness
-tingling
-optic neuritis / unilateral vision loss
-impaired gait
-urinary incon
-seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

symptoms to monitor w/ MS

A

-cognitive problems (cog fog)
-vision problems
-depression
-fatigue
-pain (acute, chronic, burning, stabbing)
-bowel/bladder
-weakness
-sexual issues
-muscle stiffness/spasm
-walking/balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

cog fog

A

difficulty thinking clearly and concentrating
not a memory thing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

is there a cure to MS

A

no

19
Q

goals of therapy for MS

A

-slow disability
-reduce frequency of relapses
-reduce new brain lesions

20
Q

drugs for MS are used to

A

-modify the disease process
-treat an acute relapse
-manage symptoms

21
Q

how do we modify the disease process

A

-interferon beta (injectable)
-glatiramer acetate (injectable)

22
Q

interferon beta

A

-avonex (1a)
-betaseron (1b)
-extavia (1b)
-plegridy (pegylated 1a)
-rebif (1a)
natural occur in body

23
Q

glatiramer acetate

A

-copaxone
-glatopa

24
Q

interferon beta MOA

A

inhibit pro-inflammatory WBCs from crossing BBB
decrease relapse rate by up to 30%

25
Q

interferon beta SE

A

-flu like
-liver toxicity
-bone marrow suppression
-depression
-drug interaction

26
Q

glatiramer acetate MOA

A

increased production of anti inflammatory T cells which cross the BBB and suppress inflammation

27
Q

glatiramer acetate SE

A

-injection site reactions
-post injection reactions
-flushing, palpitations, chest pain, rash, laryngeal constriction (lasts 15-20 mins, treatment not necessary)

28
Q

oral MS medications

A

-fingolimod
-dimethyl fumarate

29
Q

infusion MS drugs

A

natalizumab

30
Q

fingolimod

A

retain lymphocytes in the lymph nodes, preventing them from crossing the BBB -> decreasing inflammation
helps w/ RRMS

31
Q

dimethyl fumarate

A

thought to inhibit immune cells and may have anti oxidant properties

32
Q

natalizumab MOA

A

prevents circulating T cells from leaving the vasculature and crossing blood brain barrier

33
Q

natalizumab therapeutic uses

A

-MS (reduces relapse by 68%), relapsing form
-Crohn’s disease
monotherapy only

34
Q

natalizumab SE

A

headache & fatigue
-progressive mutlifocal leukoencephalopathy (fetal, to be on this drug need to be in program that is very regulated)
-hepatotoxicity
-hypersensitivity

35
Q

what increases the risk of PML while on natalizumab

A

use of other immunosuppressants in combo w/ it (steroids)

36
Q

alemtuzumab

A

reserved for patients w/ poor response to 2 or more MS meds

37
Q

mitozantrone

A

-secondary progressive
-progressive relapsing
-worsening RRMS (w/o complete remission)

38
Q

treating an acute relapse: preferred treatment

A

high does IV glucocorticoid short term

39
Q

treating an acute relapse: non preferred

A

-IV gamma globulin -> used if pt is intolerant to glucocorticoids
-ACTH (H.P. acthar gel) which prolongs the release of ACTH after injection

40
Q

managing sx drugs to use for: urinary frequency / retention

A

anticholinergic / cholinergic

41
Q

managing sx drugs to use for: constipation

A

bulking forming laxative

42
Q

managing sx drugs to use for: fatigue

A

amantadine

43
Q

managing sx drugs to use for: muscle spasms

A

muscle relaxants

44
Q

managing sx drugs to use for: cognitive dysfunction

A

donepezil